Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04947800 · ClinicalTrials.gov registry record · NA
Acupuncture to Enhance for Pulmonary Rehab
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT04947800: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT04947800 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04947800, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The investigator is investigating if acupuncture may improve pulmonary function, exercise tolerance, stress and modulate the inflammatory effects of chronic obstructive pulmonary disease (COPD). The investigator would like to measure the effect of the combination of acupuncture with standard pulmonary rehab in patients with COPD.
Primary Outcome
Change in Forced expiratory volume in one second (FEV1) as measures by spirometry test
Interventions
- DEVICE Pulmonary rehabilitation program + EA Lung Mu-Shu+ St36
- DEVICE Pulmonary rehabilitation program + Lv7/Gb26
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-01-25 |
| Est. Completion | 2024-06-01 |
| Phase | NA |
Why NCT04947800 stopped before completion
NCT04947800 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Pulmonary rehabilitation program + EA Lung Mu-Shu+ St36 is the first listed.
NCT04947800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04947800 about?
NCT04947800 is a clinical study titled "Acupuncture to Enhance for Pulmonary Rehab". The investigator is investigating if acupuncture may improve pulmonary function, exercise tolerance, stress and modulate the inflammatory effects of chronic obstructive pulmonary disease (COPD). The investigator would like to measure the effect of the combination of acupuncture with standard pulmona...
What is the current status of trial NCT04947800?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2022-01-25. Estimated completion is 2024-06-01.
What interventions are being tested in trial NCT04947800?
The interventions under investigation include: Pulmonary rehabilitation program + EA Lung Mu-Shu+ St36 (DEVICE), Pulmonary rehabilitation program + Lv7/Gb26 (DEVICE).
Who is sponsoring clinical trial NCT04947800?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04947800's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI